Avanos Medical, Inc.
AVNS
Revenue
170.40M
▼-1.30M▼-0.7571%
3 Months ChangeAssets
1.66B
▼-1.60M▼-0.09651%
3 Months ChangeLiabilities
426.50M
▼-9.30M▼-2.13%
3 Months ChangeFree Cash Flow
-12.10M
▼-1.30M▼-12.04%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-30
Form 10-Q
ID: 0001606498-24-000084
2024-10-30
Form 8-K
ID: 0001606498-24-000082
2024-07-31
Form 10-Q
ID: 0001606498-24-000077
2024-07-31
Form 8-K
ID: 0001606498-24-000074
2024-07-01
Form 8-K
ID: 0001606498-24-000069
2024-05-13
Form 8-K
ID: 0001606498-24-000060
2024-05-02
Form 10-Q
ID: 0001606498-24-000058
2024-05-02
Form 8-K
ID: 0001606498-24-000055
2024-04-29
Form 8-K
ID: 0001606498-24-000053
2024-02-20
Form 8-K
ID: 0001606498-24-000016